Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
SKG-II-SF
- Specification
- Recommended Products
Store in liquid nitrogen.
- Q & A
- Customer Review
Targeted therapies for uterine/cervix tumor cells have seen advancements in recent years. For example, the use of immune checkpoint inhibitors, such as pembrolizumab, has shown promising results in certain cases of advanced or recurrent uterine/cervix cancers. Additionally, targeted therapies that inhibit specific molecular pathways, such as inhibitors of the PI3K/AKT/mTOR pathway, are being explored in clinical trials.
Average Rating: 4.0 | 1 Scientist has reviewed this product
An excellent choice
I've been using this cell product for regenerative medicine research, and it has proven to be an excellent choice. The cells displayed the desired differentiation potential and contributed to tissue repair.
10 Feb 2023
Ease of use
After sales services
Value for money
Customer Support & Price Inquiry